No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Amgen Is Maintained at Equal-Weight by Wells Fargo
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Cuts Target Price to $280
Express News | Amgen Inc. : Wells Fargo Cuts Target Price to $280 From $335
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Goldman Sachs lowered Amgen's Target Price to $370.
Gelonghui, January 9 | Goldman Sachs: Downgraded Amgen's Target Price from $375 to $370, maintaining a "Buy" rating. (Gelonghui)
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $370